HomeInsightsStock Comparison

Beryl Drugs Ltd vs Strides Pharma Science Ltd Stock Comparison

Beryl Drugs Ltd vs Strides Pharma Science Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Beryl Drugs Ltd is ₹ 20.34 as of 22 Jul 12:17.
  • The P/E Ratio of Beryl Drugs Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Strides Pharma Science Ltd changed from 79.4 on March 2020 to 1.7 on March 2025 . This represents a CAGR of -47.30% over 6 years.
  • The Market Cap of Beryl Drugs Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Strides Pharma Science Ltd changed from ₹ 2888 crore on March 2020 to ₹ 6165 crore on March 2025 . This represents a CAGR of 13.47% over 6 years.
  • The revenue of Beryl Drugs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Strides Pharma Science Ltd for the Mar '25 is ₹ 1205 crore as compare to the Dec '24 revenue of ₹ 1160 crore. This represent the growth of 3.9%.
  • The ebitda of Beryl Drugs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Strides Pharma Science Ltd for the Mar '25 is ₹ 205.56 crore as compare to the Dec '24 ebitda of ₹ 214.45 crore. This represent the decline of -4.15%.
  • The net profit of Beryl Drugs Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Strides Pharma Science Ltd changed from ₹ -9.36 crore to ₹ 85.62 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Beryl Drugs Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Strides Pharma Science Ltd changed from 104.26 % on March 2020 to 1.28 % on March 2025 . This represents a CAGR of -51.97% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Beryl Drugs Ltd

  • Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993.
  • The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993.
  • The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange. The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally.
  • It offers I.V.fluids, and a range of small and large volume injectables.
  • It provides a range of eye/ear drops, veterinary products, and injections.

About Strides Pharma Science Ltd

  • Strides Pharma Science Limited was originally incorporated under the name 'Strides Arcolab Limited ' on June 28, 1990.
  • In FY 2016, Shasun Pharmaceuticals Limited merged with Strides Arcolab Limited forming a new identity 'Strides Shasun Limited', which became effective from 19 November, 2015 and name of the Company was changed to 'Strides Pharma Science Limited' from 'Strides Shasun Limited' effective on July 18, 2018. Strides Pharma Science is a global pharmaceutical company headquartered in Bengaluru, India.
  • The Company is an integrated manufacturer and exporter of Finished Pharmaceutical Dosage forms for both branded and generic.
  • It manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals.
  • Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semisolids.

Beryl Drugs Ltd News Hub

News

Beryl Drugs to hold board meeting

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 30 May 2025. P...

Read more

20 May 2025 16:52

News

Beryl Drugs to announce Quarterly Result

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 8 February 202...

Read more

01 Feb 2025 12:57

News

Beryl Drugs to discuss results

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 13 November 20...

Read more

06 Nov 2024 18:13

News

Beryl Drugs to hold AGM

Beryl Drugs announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

11 Sep 2024 10:44

News

Beryl Drugs to convene AGM

Beryl Drugs announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

11 Sep 2024 10:20

News

Beryl Drugs to conduct board meeting

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 3 September 20...

Read more

27 Aug 2024 11:03

Strides Pharma Science Ltd News Hub

News

Strides Pharma Science schedules AGM

Strides Pharma Science announced that the 34th Annual General Meeting(AGM) of the company ...

Read more

10 Jul 2025 10:16

News

Board of Strides Pharma Science recommends final dividend

Strides Pharma Science announced that the Board of Directors of the Company at its meeting...

Read more

22 May 2025 18:03

News

Strides Pharma Science to announce Quarterly Result

Strides Pharma Science will hold a meeting of the Board of Directors of the Company on 22 ...

Read more

17 May 2025 11:40

News

Strides Pharma's US arm acquires four drugs to bolster portfolio

The portfolio consists of liquids and immediate release solid orals which are in the thera...

Read more

30 Apr 2025 07:51

News

Strides Pharma Science announces incorporation of step-down subsidiary

Arco Lab, a wholly owned subsidiary of Strides Pharma Science has incorporated a new wholl...

Read more

11 Apr 2025 15:34

News

Strides Pharma Science announces acquisition of Singapore-based Amexel

Strides Pharma Global (SPG), a step-down wholly-owned subsidiary of Strides Pharma Science...

Read more

15 Mar 2025 15:45

SWOT Analysis Of Strides Pharma Science Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Strides Pharma Science Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Beryl Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Beryl Drugs Ltd and Strides Pharma Science Ltd

Which company has a larger market capitalization, Beryl Drugs Ltd or Strides Pharma Science Ltd?

Market cap of Beryl Drugs Ltd is 10 Cr while Market cap of Strides Pharma Science Ltd is 8,199 Cr

What are the key factors driving the stock performance of Beryl Drugs Ltd and Strides Pharma Science Ltd?

The stock performance of Beryl Drugs Ltd and Strides Pharma Science Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beryl Drugs Ltd and Strides Pharma Science Ltd?

As of July 22, 2025, the Beryl Drugs Ltd stock price is INR ₹20.34. On the other hand, Strides Pharma Science Ltd stock price is INR ₹889.65.

How do dividend payouts of Beryl Drugs Ltd and Strides Pharma Science Ltd compare?

To compare the dividend payouts of Beryl Drugs Ltd and Strides Pharma Science Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions